Press Release Details

Legend Biotech Announces Participation in Upcoming Investor Conferences

August 19, 2022 at 4:01 PM EDT

SOMERSET, N.J.--(BUSINESS WIRE)--Aug. 19, 2022-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences:

Event: Citi's 17th Annual BioPharma Conference
Location: Boston, Massachusetts
Fireside Chat Date & Time: Wednesday, September 7, 2022 at 11:20am ET
Presenter: Ying Huang, Ph.D., CEO

Event: 2022 Wells Fargo Healthcare Conference
Location: Boston, Massachusetts
Fireside Chat Date & Time: Thursday, September 8, 2022 at 2:35pm ET
Presenter: Ying Huang, Ph.D., CEO

Event: Morgan Stanley Global Healthcare Conference 2022
Location: New York, New York
Fireside Chat Date & Time: Monday, September 12, 2022 at 3:40pm ET
Presenter: Ying Huang, Ph.D., CEO

Event: Jefferies Cell and Genetic Medicine Summit
Location: New York, New York
Date: September 29 & 30, 2022

About Legend Biotech

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.

Learn more at and follow us on Twitter and LinkedIn.

Investor Contacts:
Joanne Choi, Senior Manager, Investor Relations, Legend Biotech

Crystal Chen, Manager, Investor Relations, Legend Biotech

Press Contact:
Tina Carter, Corporate Communications Lead, Legend Biotech
(908) 331-5025

Source: Legend Biotech


But we are just getting started!

You are about to leave
Are you sure you want to leave so soon?


By continuing to use our site, you agree to terms on our Legal Notice.
You can learn more about how we use cookies by viewing our Legal Notice.